KEY vs PSTV · P/E 13, rev $7.51B vs P/E 0.2, rev $5.8M
KeyCorp (KEY) versus Plus Therapeutics Inc (PSTV) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Plus Therapeutics Inc (PSTV) is a biotechnology company listed on NASDAQ.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported PSTV revenue for 2024-12-31 was $5.8M. Net income was -$13.0M. Revenue was up 18.5% from 2023-12-31 to 2024-12-31. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. PSTV currently screens at market cap $29.7M and trailing P/E 0.2.
Not investment advice. Open the KEY and PSTV stock pages for the full models.
Not investment advice.